Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1A/1B Trial of Oxy(Gly)4-sKLH Vaccine in Opioid Use Disorder
NCT04458545Phase 2Recruiting
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2020
- Primary completion
- Mar 2027
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of OXY-sKLH in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Oct 2020; status: recruiting.
02
Drugs
OXY-sKLH
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04458545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458545.